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In long-lived C. elegans insulin/IGF-1 pathway mu-
tants, the life-extending FOXO transcription factor
DAF-16 is present throughout the animal, but we
find that its activity in a single tissue can delay the
aging of other tissues and extend the animal’s life
span. To better understand the topography of DAF-
16 action among the tissues,we analyzed a collection
of DAF-16-regulated genes. DAF-16 regulated most
of these genes in a cell-autonomous fashion, often
using tissue-specific GATA factors to direct their
expression to specific tissues. DAF-16 could also
act cell nonautonomously to influence gene expres-
sion. DAF-16 affected gene expression in other cells,
at least in part, via the lipid-gene regulator MDT-15.
DAF-16, and probably MDT-15, could act cell non-
autonomously in the endoderm to ameliorate the
paralysis caused by expressing Alzheimer’s Ab pro-
tein in muscles. These findings suggest that MDT-
15-dependent intercellular signals, possibly lipid
signals, can help to coordinate tissue physiology,
enhance proteostasis, and extend life in response
to DAF-16/FOXO activity.
INTRODUCTION
Insulin and IGF-1 signaling pathways influence the rate of aging
in many species, and they appear to affect human aging, as well
(Barzilai et al., 2012; Kenyon, 2010). However, the mechanisms
by which insulin and IGF-1 hormones coordinate the aging of
individual tissues are poorly understood. In C. elegans, the life-
span extension produced by reduced insulin/IGF-1 signaling
requires the FOXO transcription factor DAF-16 (Kenyon et al.,
1993; Lin et al., 1997; Ogg et al., 1997). DAF-16/FOXO is an
important longevity regulator, as its disruption accelerates the
rate of normal aging (Garigan et al., 2002; Haithcock et al.,
2005)—and increasing its activity can extend life span (Hender-
son and Johnson, 2001; Lee et al., 2001; Lin et al., 2001). Its
function in life-span regulation may be ancient: forkhead-boxCtranscription factors can extend life span in yeast (Postnikoff
et al., 2012), and FOXO proteins can extend the life span of
Drosophila (Giannakou et al., 2004; Hwangbo et al., 2004) and
possibly humans (Barzilai et al., 2012).
DAF-16 extends the life span of C. elegans insulin/IGF-1-
pathway mutants by affecting the expression of stress-
response, metabolic, innate-immunity, signaling, germline, and
other genes (Curran et al., 2009; Lee et al., 2003; McElwee
et al., 2003; Murphy et al., 2003; Wang et al., 2008). Presumably,
these genes hold much of the answer to the question of how life
span can be extended; yet, we know little about their positions in
this regulatory network. How are their activities distributed
among the different tissues? In which tissues are their activities
altered in long-lived mutants? Is each gene regulated directly
by DAF-16, or are intermediate, possibly intercellular, factors
required? These are fascinating, system-wide questions that
address the function of this endocrine pathway as a whole.
DAF-16 is expressed in many tissues, raising the possibility
that it directly regulatesmany genes in a strictly cell-autonomous
fashion. Consistent with this idea, expressing daf-16(+) exclu-
sively in the intestine, muscles or neurons of a daf-2() mutant
switches on the sod-3 superoxide dismutase gene in that tissue
alone (Libina et al., 2003). The sod-3 promoter contains
consensus DAF-16/FOXO-binding elements (DBEs) (Biggs
et al., 2001; Furuyama et al., 2000; Pierrou et al., 1994), which
bind DAF-16 both in vitro (Furuyama et al., 2000) and in vivo
(Oh et al., 2006).
DAF-16 activity can also influence cells at a distance. First, in
a process we call FOXO-to-FOXO signaling, increasing daf-16
gene dosage in one tissue (neurons, intestine) upregulates
DAF-16 activity in other tissues (Libina et al., 2003). Intestinal
DAF-16 mediates FOXO-to-FOXO signaling, at least in part, by
downregulating an intestinal insulin gene (Murphy et al., 2007).
The C. elegans intestine is the animal’s entire endoderm, also
functioning as the adipose tissue, liver, and pancreas. Consistent
with this, overexpressing dFOXO specifically in the fat body of
Drosophila reduces the expression of the insulin-like peptide
gene dilp-2 in neurons and reduces insulin/IGF-1 signaling in
peripheral tissues (Giannakou et al., 2004; Hwangbo et al., 2004).
DAF-16 also appears to initiate a fundamentally different
type of cross-tissue communication, one that does not require
DAF-16 activity in responding tissues. Expressing daf-16 exclu-
sively in the intestine of a daf-16(); daf-2() double mutantell Metabolism 17, 85–100, January 8, 2013 ª2013 Elsevier Inc. 85
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nonintestinal tissues extends life span by 50% (Libina et al.,
2003). To a lesser extent, DAF-16 can also act exclusively in
neurons (Libina et al., 2003) or skin (this study) to increase life
span, as well. The finding that DAF-16 is not absolutely required
in any one tissue to extendC. elegans’ life span implies that DAF-
16 can extend life span by modulating expression of genes en-
coding downstream hormones or metabolites that act indepen-
dently of daf-16 to delay aging in responding tissues. If so, then
genes like sod-3, which require DAF-16 cell autonomously for
their expression, might be the exception and not the rule.
To address these questions more systematically, in vivo,
we surveyed longevity genes that are either up- or downregu-
lated by DAF-16 in long-lived daf-2(-) mutants to ask (1) in
which tissues they are expressed; (2) whether DAF-16 regulates
them in a strictly cell-autonomous fashion, or remotely, at a
distance; and (3) what mechanisms control their tissue-specific
expression.
RESULTS
DAF-16 Can Affect Tissue Aging at a Distance
daf-2() mutants expressing daf-16 only in the intestine are
long-lived (Libina et al., 2003) (Table S3 and Figure S6A), but is
this increased longevity correlated with a more youthful appear-
ance of individual tissues? Aging C. elegans muscles resemble
those of human sarcopenia patients, in which muscle filaments
fragment and break. We found that expressing daf-16 exclu-
sively in the intestine of daf-16(); daf-2() mutants reduced
this muscle deterioration (Figures 1A and 6A) and improved
body movement (Figure S6B). Thus, intestinal DAF-16 can act
at a distance to delay the aging of daf-16() muscles.
Analysis of DAF-16-Regulated Genes In Vivo
To better understand the DAF-16 regulon at the tissue level, we
studied, in vivo, a diverse collection of DAF-16-regulated genes
that we had identified in gene-expression arrays comparing
long-lived daf-2() mutants to daf-16(); daf-2() mutants
(Murphy et al., 2003). Our set included stress-resistance, chap-
erone, signaling, innate immunity, and metabolic genes whose
RNAi knockdown influenced life span, as well as additional
genes for which RNAi analysis had not been performed.Figure 1. DAF-16 Acts Cell Nonautonomously to Regulate Muscle Agin
(A) Intestinal DAF-16 protects daf-16()muscles from age-dependent deterioratio
scored/animals analyzed) (see Supplemental Experimental Procedures) (Man
Percentages of animals with extensive degeneration (Class C, as defined by Her
sarcomere of a day 10 Class C animal is shown; 250X magnification. Scale bar: 5
seen in nontransgenic daf-16(+); daf-2() mutants, just as it does not extend life
(B) Left panels: A mtl-1::rfp translational reporter is expressed mainly in the pha
daf-2() mutants in a daf-16-dependent manner. Right panels: intestinal GFP-ta
daf-16 does not affectmtl-1::rfp expression. The body is outlined. daf-2(e1370) an
bar: 130 mm.
(C) The ges-1 promoter, which drives gfp::daf-16 expression, is expressed in
expression in the same cells (left panel). Young adults, 100X magnification. Scal
(D) Top panels: A nuclear-localized Pdod-17::rfp transcriptional reporter is express
daf-2()mutants and upregulated in daf-16(); daf-2()mutants. Bottom panels
Pdod-17::rfp expression. Inset: daf-16 expression (green) is inversely correlated w
intestinal cell that does not express gfp::daf-16 (arrowhead). The body and pha
Representative images from 2 or more experiments are shown for all figures.
CWe analyzed the expression of each gene by using 1–3 kb
upstream DNA to drive expression of red fluorescent protein
(RFP), or, in a few cases, green fluorescent protein (GFP). We
first examined each reporter for its response to daf-2 RNAi,
which stimulates DAF-16/FOXO’s transcriptional activity.
Twenty of the forty-four new genes we tested exhibited the
predicted (up or down) response to daf-2 inhibition (Table S1).
The 24 negatives could include microarray false positives, or
genes influenced by regulatory elements downstream of the
promoter. Consistent with this, the mtl-1 transcriptional fusion
exhibited little or no response to daf-2 RNAi, but a translational
fusion driven by the same promoter responded very strongly
(Figures 1B and S1C).
Genes Upregulated in Long-Lived daf-2(–) Mutants
Fifteen of the twenty daf-2-sensitive reporters were upregulated
under daf-2() conditions (Table S1). One, lys-7, encodes an
innate-immunity lysozyme. Several, like sod-3, were stress-
resistance genes: mtl-1 encodes a metallothionein protein that
confers resistance to heavy metals. hsp-12.6 and hsp-16.2
encode small heat-shock proteins that contribute to the isotonic
stress resistance of insulin/IGF-1-pathway mutants (Lamitina
and Strange, 2005), as do four additional proteins, encoded
by hgo-1 (homogentisate 1,2-dioxygenase), tps-1 and tps-2
(trehalose-6-phosphate synthases), and tre-4 (trehalase) (Lami-
tina and Strange, 2005). In addition, several genes encode
metabolic enzymes, including gpd-2 (glyceraldehyde-3-phos-
phate dehydrogenase), nnt-1 (nicotinamide nucleotide transhy-
drogenase), dod-11 (sorbitol dehydrogenase), and dod-8 (17
beta-hydroxysteroid dehydrogenase). F09F7.7 and ZK384.3
encode proteins that are similar to human a-ketoglutarate-
dependent dioxygenase and gastricsin, respectively. Finally,
sma-10 encodes a TGF-b-pathway member.
daf-2 and daf-16 act exclusively during adulthood to influence
aging (Dillin et al., 2002), so we examined expression during early
adulthood. In thewild-type, 13 of the 15 geneswere expressed in
more than one tissue, and, with few exceptions (dod-8, tps-2,
and nnt-1), their expression increased in each of those tissues
under daf-2() conditions (Table S1). Interestingly, all but one
of these upregulated genes was expressed and upregulated in
the intestine. Moreover, three genes whose functions contribute
to the longevity of daf-2() mutants (lys-7, mtl-1, and hsp-16.2)g and Autonomously to Regulate mtl-1 and dod-17 Expression
n. Top: Extent of sarcomere degeneration on day 10 of adulthood (micrographs
n-Whitney-Wilcoxon test of all data points; n.s., not significant). Bottom:
ndon et al. [2002]) (Student’s t test of independent experiments). A gap in the
0 mm. Note that intestinal daf-16(+) does not fully restore muscle quality to that
span to the extent seen in daf-16(+); daf-2() animals.
rynx (ph) and intestine (i) of wild-type, and is upregulated in the intestines of
gged DAF-16 upregulates mtl-1::rfp only in the intestine. Muscle or neuronal
d daf-16(mu86)mutations were used. Young adults, 100X magnification. Scale
a mosaic fashion in the intestine (middle panel). DAF-16 turns on mtl-1::rfp
e bar: 130 mm.
edmainly in the intestine (i) of wild-type and is downregulated in the intestine of
: expression of daf-16 in the intestine, but not muscles or neurons, suppresses
ith dod-17 expression (red). Note that Pdod-17::rfp expression is higher in an
rynx (ph) are outlined. Young adults, 250X magnification. Scale bar: 50 mm.
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DAF-16 Activity Within and Across the Tissues(Murphy et al., 2003; Walker and Lithgow, 2003) were expressed
and upregulated only in the intestine.
Genes Downregulated in Long-lived daf-2(–) Mutants
DAF-16 also downregulates genes in daf-2() mutants, and
RNAi knockdown of certain downregulated genes lengthens
wild-type life span (Murphy et al., 2003). We analyzed: pept-1,
which encodes a predicted dipeptide transporter; vit-5, which
encodes a putative lipid transporter related to vertebrate vitello-
genins and mammalian ApoB-100, a core LDL particle constit-
uent; his-24, which encodes a C. elegans H1 linker histone;
ZC416.6, similar to human leukotriene A-4 hydrolase; and one
gene with unknown function, dod-17. Remarkably, all five genes
were expressed only in the intestine (or intestine plus pharynx)
(Table S1).
DAF-16 Regulates Many Genes Cell Autonomously
Next, we chose nine genes with strong daf-2() induction ratios
for DAF-16 cell-autonomy studies. We introduced transgenic
reporters for these genes into daf-16(); daf-2() mutants in
which daf-16 was expressed in only one tissue: intestine,
neurons, or muscles. We confirmed the tissue specificity of
daf-16 expression by using a functional GFP::DAF-16 protein
fusion (Libina et al., 2003). Surprisingly, as with sod-3 (Libina
et al., 2003); used as a control), six of these nine genes were
regulated in a strictly cell-autonomous fashion (lys-7, mtl-1,
hgo-1, gpd-2, nnt-1, and dod-17). The demonstration of cell
autonomy was particularly striking in the intestine, because the
ges-1 intestinal promoter we used did not fire evenly in all cells.
We observed a close correlation between GFP::DAF-16 and
reporter expression among individual intestinal cells with each
of these six genes (Figure 1C, mtl-1; Figure 1D, dod-17; Fig-
ure S1B, lys-7), plus sod-3 (Figure S1A).
DAF-16 Binds Multiple DNA Sequences to Upregulate
Gene Expression
Does DAF-16 bind directly to genes that it regulates cell autono-
mously? All but one of the 20 new DAF-16-regulated transgenes
we analyzed contain at least one copy of the canonical DAF-16-
binding element, consistent with this possibility. Previously,
Schuster et al. (2010) demonstrated DAF-16 binding to theFigure 2. DAF-16 and GATA Factors Bind to dod-8 Promoter Sequenc
(A) The 504 bp dod-8 promoter fragment drives gfp (cytoplasmic) expression in t
type and is upregulated in most tissues of daf-2() mutants. Deletion of the D
significantly attenuated intestinal expression and abolished hypodermal expressi
Scale bar: 50 mm.
(B) Bacterially expressedGST-taggedDAF-16 gel-shifted an oligonucleotide cont
abolished the binding. Shifted oligos are highlighted. Mock: purified GST. Repres
(C) DAF-16 gel-shifted the 504 bp dod-8 promoter fragment independently of the
antibody, could be inhibited with cold competitor, a dod-8 promoter fragment
fragment following DAE deletion.
(D) Knockdown of daf-16 or elt-2/GATA significantly attenuated Pdod-8::gfp ind
(100X) using a low exposure to avoid signal saturation. Scale bar: 130 mm. Lower
was quantified. Bars, mean value ± SD. daf-2(+) background: RNAi control, n = 36
elt-2(RNAi), n = 36, p = 2.32E-08. daf-2() background: RNAi control, n = 24; da
(E) Both ELT-2 and ELT-3 gel-shifted DAE/GATA site-containing DNA. Binding
a mutant DAE/GATA()-promoter fragment. Likewise, neither ELT-2 nor ELT-3 c
copurified proteins produced by the empty vector pET-28.
(F) Both ELT-2 and DAF-16 gel-shifted wild-type but not mutant DAE/GATA seq
(G) Model for coregulation of dod-8 by DAF-16 and GATA factors. Note that DAF
CDBE-containing genes hsp-12.6, hgo-1, tps-1, gpd-2, and
F09F7.7 in chromatin profiling experiments. We tested for
DAF-16’s binding to our eleven most highly regulated genes,
plus sod-3, in chromatin immunoprecipitation (ChIP) experi-
ments. In our experiments, DAF-16 bound to sod-3, dod-8,
hsp-12.6, and tps-1 preferentially in daf-2() mutants in both of
two experiments, and to mtl-1, nnt-1, hgo-1, dod-11, and
dod-17 in one of two experiments (see Figure S4D for details).
We also examined the online modENCODE database for DAF-
16 binding profiles for these same genes (http://intermine.
modencode.org/release-30/report.do?id=64000352). Even in
wild-type, in which DAF-16 is only partially activated, DAF-16
bound to genomic regions of ten of these twelve genes (sod-3,
dod-8, mtl-1, gpd-2, nnt-1, hgo-1, tps-1, tps-2, dod-11, and
hsp-12.6) (Figure S4D).
The one daf-2/daf-16-responsive reporter that lacked a DBE
contained a small, 0.5 kb, dod-8 promoter sequence (Figures
2A and S2). This reporter was noteworthy, as, to our knowledge,
DAF-16 has not been shown to bind any non-DBE sites in
C. elegans. One potential DAF-16-binding site in this fragment
was the so-called DAE (DAF-16-associated element, CTTATCA),
as this sequence is overrepresented in promoter regions of
DAF-16-regulated genes (Murphy et al., 2003). The DAE was
significant in vivo, as deleting it prevented a daf-2 mutation
from upregulating Pdod-8::gfp expression (Figure 2A). In gel-
shift assays, DAF-16 bound to an oligonucleotide that contained
six tandem wild-type copies (but not six mutant copies) of this
site (Figure 2B). Thus, DAF-16 can bind the DAE.
Unexpectedly, we found that DAF-16 was able to bind to the
0.5 kb dod-8 promoter fragment lacking the DAE (but not to
control plasmid DNA) (Figures 2C and S3B). Thus, we looked
for additional DAF-16-binding sites. Certain suboptimal DBE-
like sites with a conserved core sequence ‘‘AAACAA’’ have
been observed in upstream sequences of several FOXO-
regulated genes (Santo et al., 2006; Tran et al., 2002). Some of
these are functionally significant (Tran et al., 2002). The dod-8
promoter contains different suboptimal DBEs (Figure S3A).
We found that DAF-16 bound to dod-8 promoter-derived oligo-
nucleotides that contained these motifs, but not to random
oligonucleotides (Figure S3A). Removing these sites in the
transgene prevented hypodermal Pdod-8::gfp expressiones In Vitro and Regulate dod-8 In Vivo
he intestine (i), hypodermis (h), body-wall muscles (m), and neurons (n) of wild-
AE did not have marked effects on Pdod-8::gfp expression in wild-type but
on in daf-2()mutants (right, bottom panel). Young adults, 250X magnification.
aining three DBEs or, to a lesser extent, six DAEs. DBE andDAE pointmutations
entative autoradiograph from two or more experiments is shown for all figures.
DAE. Left block: DAF-16 binding, which could be super-shifted with a DAF-16
that lacked the DAE. Right block: DAF-16 still bound to the dod-8 promoter
uction in the intestine of daf-2() mutants. Young adults were photographed
panel: The GFP signal in the anterior quarter of the intestine (‘‘i,’’ as indicated)
(animals); daf-16(RNAi), n = 36, p = 2.19E07 (Student’s t test, versus control);
f-16(RNAi), n = 20, p = 2.69E17; elt-2(RNAi), n = 24, p = 3.21E10.
could be competed away by a wild-type dod-8 promoter fragment, but not
ould gel-shift the dod-8 promoter fragment lacking the DAE/GATA site. Mock:
uences. Mock: purified GST.
-16 can bind additional, unidentified promoter sites, as well.
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Table 1. ELT-2 and ELT-3 Are Required for Expression of Some DAF-16-Regulated Genes
Gene
Reporter
Expression under
daf-2() Conditions
Promoter Used for Analysis Expression upon RNAi
Length (kb) DBE DAE GATA daf-16() elt-2(-) elt-3(-)
sod-3 Up, intestine, hypodermis,
muscles, neurons
1.1 4 + 1 sub 0 4 Down Down (intestine,
modest)
No Change
dod-8(*) Up, intestine, hypodermis,
muscles, neurons
0.5 0* 1 1 Down Down (intestine) Down (hypodermis)
lys-7 Up, intestine 3.1 7 + 4 sub 1 10 Down Down (intestine) No Change
mtl-1 Up, intestine 3.6 5 + 15 sub 2 12 Down Down (intestine) No Change
gpd-2 Up, intestine 1.1 1 0 2 Down Down (intestine,
modest)
No Change
nnt-1 Up, intestine, hypodermis 1.9 10 + 6 sub 0 8 Down Down (intestine) Down (hypodermis)
hgo-1 Up, intestine, hypodermis 2.9 4 + 9 sub 1 12 Down Down (intestine) Down (hypodermis)
tps-1 Up, intestine, muscles 2.8 6 + 2 sub 1 10 Down No Change No Change
tps-2 Up, hypodermis, muscles 2.9 5 + 8 sub 1 12 Down No Change Down (hypodermis)
dod-11 Up, intestine, hypodermis,
muscles
5.3 6 + 14 sub 2 10 Down Down (intestine,
modest)
No Change
hsp-12.6 Up, intestine, hypodermis,
muscles
2.7 9 + 13 sub 0 11 Down Down (intestine) No Change
dod-17 Down, intestine 2.6 4 + 7 sub 0 10 Up No Change No Change
The table lists the 12 genes analyzed for ELT-2 and ELT-3 influence. These genes were chosen because their expression was most strongly changed
by daf-2 RNAi. DBE, RTAAAYA, R = A/G, Y = C/T; DAE, CTTATCA; GATA, WGATAR, W = A/T; sub, suboptimal DBE (e.g., TAAAACAA and TTGTTTGT
[Santo et al., 2006; Tran et al., 2002]). RNAi experiments were initiated at the L4 stage, 25C, and RNAi-treated animals were analyzed as young adults.
At least two independent RNAi experiments were performed, and at least ten transgenic animals were analyzed for each reporter. *: There are two
DBEs 0.66 kb upstream of the dod-8 translational start site, not included in the 0.5 kb promoter fragment we analyzed.
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of daf-2() mutants (Figure S3C). Thus, these sites appear to
play an important role in vivo.
Unexpectedly, DAF-16 still bound to the dod-8 promoter in
the absence of the DAE site and all three noncanonical binding
sites (Figure S3B). Thus, additional site(s) may contribute to
daf-16-dependent dod-8 expression in vivo, especially since,
compared with the canonical DBE, DAF-16 appeared to have
much lower affinity for the DAE and other noncanonical sites
(Figures 2B and S3A).
GATA Factors Bind to the DAE and Regulate
the Expression of Pdod-8::gfp
Since DAF-16 boundmany sites in the dod-8 promoter fragment,
we wondered why the DAE was so important in vivo. The DAE
is the reverse complement of the mammalian GATA factor
binding site (Plumb et al., 1989). Thus, the DAE site in dod-8
might also be recognized by GATA factors. C. elegans has at
least fourteen GATA-factor genes (Kormish et al., 2010; Maduro
and Rothman, 2002). Using RNAi, we knocked down ten charac-
terized GATA factors (elt-1, elt-2, elt-3, elt-5(egl-18), elt-6, elt-7,
end-1, end-3, andmed-1/med-2). Knocking down elt-2, which is
expressed in the intestine, specifically decreased intestinal
expression of Pdod-8::gfp (Figure 2D). In contrast, knocking
down elt-3, which is expressed in the hypodermis but not the
intestine (Gilleard et al., 1999; Tonsaker et al., 2012) (data not
shown), specifically decreased hypodermal expression (Fig-
ure S4C and Table 1).
Both ELT-2 and ELT-3 bound to the wild-type dod-8 promoter
in vitro, but not to a DAE-mutant dod-8 promoter (Figure 2E)
or DAE-mutant oligonucleotide (Figure 2F). As expected, the90 Cell Metabolism 17, 85–100, January 8, 2013 ª2013 Elsevier Inc.dod-8 promoter could bind GATA factors and DAF-16 at the
same time (Figures S4A and 2G). In vivo, knocking down either
daf-16 or elt-2 did not further reduce expression of the Pdod-
8::gfp reporter that lacked the DAE (Figure S4B). Together, these
results suggested that ELT-2 and ELT-3 recognize the DAE/
GATA site in vivo, thereby promoting expression of dod-8 in
daf-2() mutants.
GATA Factors and DAF-16 Coregulate a Subset
of DAF-16 Target Genes
We tested the 12 reporters that exhibited the greatest change
under daf-2() conditions for elt-2 and elt-3 dependency.
Knockdown of the intestinal GATA-factor gene elt-2 affected 9
of these 12 reporters (sod-3, dod-8, lys-7, mtl-1, gpd-2, nnt-1,
hgo-1, dod-11, and hsp-12.6), and only in the intestine (Table
1). Likewise, knockdown of the hypodermal factor elt-3 affected
dod-8, nnt-1, hgo-1, and tps-2 reporters, and only in the hypo-
dermis. Using qPCR, we found that RNAi inhibition of elt-2,
but not elt-3, resulted in significant attenuation of a subset of
intestine-expressed DAF-16 target genes in daf-2() mutants,
including sod-3, lys-7, mtl-1, nnt-1, and hgo-1 (Figure 3A).
Notably, all of the gene reporters that responded to GATA-factor
knockdowns contained at least one DAE/GATA site in their
promoters. Together, these results suggested that DAF-16 and
tissue-specific GATA factors collaborate to establish tissue-
specific expression of multiple downstream target genes.
The strong influence that the intestinal ELT-2 GATA factor had
on the expression of DAF-16 targets suggested that elt-2 might
be required for the long life spans of daf-2() mutants. elt-2 is
essential for development of the intestine (Fukushige et al.,
1998; Kormish et al., 2010). We found that adult-only RNAi
AB
C
Figure 3. The ELT-2 GATA Factor Regulates
DAF-16 Target Genes and Extends Life Span
(A) elt-2 knockdown affected the expression of
a subset of DAF-16-regulated genes in daf-2()
mutants. RNAi-sensitive rrf-3() mutants were
used for RT-qPCR analysis. Bars, mean value ±
SD, four biological replicates, technical triplicates.
Gene expression was normalized to the gene
nhr-23 (Supplemental Experimental Procedures).
Student’s t test, *p < 0.05; **p < 0.01; ***p < 0.001.
(B) Knockdown of daf-16 or elt-2 shortens the
life span of daf-2() mutants. Representative
data from at least six independent RNAi experi-
ments are shown (see Table S2). Log-rank test,
***p < 0.001.
(C) Increasing elt-2 gene dosage increases life
span. Life span was increased (7%–30%) in two
independent lines (see Table S2). Log-rank test,
***p < 0.001.
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ened the life span of wild-type by 10%–20%, but consistently
produced a stronger, 30%–45% shortening of life span, and
reduced heat-stress resistance in daf-2() mutants (Figure 3B
and Table S2). elt-2 inhibition also shortened the life span of
calorically restricted eat-2 mutants and germline-less glp-1
mutants substantially (by 40%–50% and by 25%, respectively),
but it did not preferentially shorten the long life spans of respira-
tion mutants (Table S2). Finally, increasing elt-2 gene dosage
(Fukushige et al., 1999) increased the life span of wild-type by
7%–28% (Figure 3C and Table S2). Thus, activity of the intestinalCell Metabolism 17, 85–1GATA-factor ELT-2 during adulthood has
an important influence on the life span of
C. elegans.
elt-3 played an important role in the up-
regulation of four DAF-16-controlled
genes in the hypodermis (skin). Consis-
tent with this, we found that hypo-
dermal-only daf-16 expression was able
to increase the life span of a daf-16();
daf-2() mutant by 16% and 32% in two
experiments (Figure S7). However, when
we removed elt-3 in daf-2() mutants,
we did not observe a decrease in life
span (Figures S5A–S5C). This apparent
paradox suggests that DAF-16 can regu-
late important hypodermal life-span
genes independently of ELT-3.
DAF-16 Regulates Some Target
Genes Cell Nonautonomously
Three of the nine genes we analyzed for
cell autonomy, the sorbitol dehydroge-
nase gene dod-11, the small heat-shock
protein gene hsp-12.6, and the steroid
dehydrogenase gene dod-8, were regu-
lated cell nonautonomously by DAF-16.
dod-11: In daf-2() mutants express-
ing daf-16(+) only in the intestine, expres-sion of Pdod-11::rfp was induced in the hypodermis and
muscles in multiple independent lines (Figures 4A and 4B).
(Again, we confirmed the tissue specificity of GFP::DAF-16 using
fluorescence microscopy.) Thus, DAF-16 causes intestinal cells
to make a signal that can activate dod-11 independently of daf-
16 in other tissues. Within the intestine itself, GFP::DAF-16-posi-
tive cells generally expressed Pdod-11::rfp, but we observed
exceptions (Figure 4A). Thus, DAF-16 might regulate dod-11 in
a partially cell-nonautonomous fashion within the intestine, as
well. The intestine was not the only tissue capable of affecting
dod-11 expression elsewhere in the animal: animals expressing00, January 8, 2013 ª2013 Elsevier Inc. 91
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muscles, intestine, and hypodermis (Figure 4A).
hsp-12.6: Intestine-expressed daf-16 induced hsp-12.6
expression in the intestine as well as in daf-16() tissues, such
as the hypodermis (Figure 4C). In addition, muscle-expressed
daf-16 was able to induce the hsp-12.6 reporter in both muscles
and hypodermis (Figures 4C and 4D).
dod-8: In two independent transgenic lines, intestinal DAF-16
activity strongly attenuated dod-8 reporter expression in the
hypodermis and muscles (Figure S2). Together, these findings
indicate that DAF-16 action in any of several tissues can influ-
ence gene expression independently of daf-16, either positively
or negatively, elsewhere in the animal. These findings provide
molecular correlates for DAF-16’s ability to affect the aging of
tissues in which it is not expressed.
The Lipid-Gene Regulator MDT-15 and Longevity
How does DAF-16 influence gene expression at a distance? To
address this question, we used RNAi to test250 DAF-16-regu-
lated genes (twice, in two independent experiments) for their
effects on dod-11 expression in daf-2() mutants, and in daf-
2() mutants expressing daf-16(+) only in the intestine. One
RNAi clone, for mdt-15, sharply decreased dod-11 expression
in both strains (Figures 5A and 5B). mdt-15 transcriptional
reporters (Taubert et al., 2006) (obtained from the Genome
BC C. elegans Gene Expression Consortium), as well as RNA
in situ hybridizations (The Nematode Expression Pattern
Database), displayed mdt-15 expression in the intestine and
some head neurons but not in the muscles or hypodermis. We
observed a similar tissue distribution ofmdt-15 reporter expres-
sion in daf-2(RNAi) strains. Thus, mdt-15 may help to mediate
DAF-16’s action at a distance.
MDT-15 is a transcriptional mediator that regulates expression
of lipid and other metabolic genes (Taubert et al., 2006, 2008).
mdt-15 is upregulated by DAF-16 in daf-2() mutants (Murphy
et al., 2003) and in long-lived germline-defective animals (Mc-
Cormick et al., 2012). mdt-15 RNAi shortened the life span of
wild-type by 20% (Figure 5C and Table S4), as reported (Tau-
bert et al., 2006). However, we found that mdt-15 RNAi short-
ened the life span of daf-2() mutants by 45%. Similarly,
mdt-15 RNAi shortened the life span of daf-16(); daf-2()
mutants by 10%–20%, but it shortened the life span of daf-
16(); daf-2() mutants expressing daf-16 in the intestine by
30% (Figures 5D and Table S4). Thus, mdt-15 is importantFigure 4. DAF-16 Regulates dod-11 and hsp-12.6 Cell Nonautonomous
(A and B) (dod-11) In (A), top panels: Pdod-11::rfp is expressed in most tissues
muscles (m) of daf-2() mutants in a daf-16-dependent manner. Bottom panel
hypodermis and muscles (compare with daf-16[]; daf-2[]). Inset: overlay of inte
(arrowhead) does not express gfp::daf-16 but does express Pdod-11::rfp. Bottom
in the intestine and hypodermis. Young adults, 250X magnification. Scale bar: 5
resulting Pdod-11::rfp expression in intestinal (i), hypodermal (h), and muscle (m
two panels: Higher magnification of the same animal, viewed using differential inte
11::rfp is expressed in the hypodermis (h) and muscles (m) when DAF-16 is activa
(C and D) (hsp-12.6) In (C), left column: Phsp-12.6::rfp is expressed at low levels
dermis; ‘‘m,’’ muscles) of daf-2()mutants in a daf-16-dependent manner. Right
hypodermis (top). Note that not all daf-16-expressing cells (green) express Phsp
muscles as well as hypodermis (middle). Neuronal DAF-16 does not affect hsp-1
in head neurons. Young adults, 250X magnification. Scale bar: 50 mm. In (D), DAF
(left column) as well as hypodermal cells (h) (right column) is shown. Young adul
Cfor wild-type longevity, and even more important for the
extended life spans of daf-2() mutants. At the tissue level,
mdt-15 RNAi reduced the ability of intestinal daf-16(+) to delay
muscle deterioration (Figure 6A), while having no significant
effects on the sarcomeres of daf-16(); daf-2() mutants.
However, mdt-15 may affect additional processes required for
movement, as mdt-15 RNAi decreased the motility of both daf-
16() and daf-16(+) animals (Figure S6C).
DAF-16 Can Act at a Distance to Protect Animals
from Amyloid Paralysis
When expressed in C. elegans’ muscles, the human Alzheimer’s
protein Ab(1-42) aggregates and paralyzes the animals during
early adulthood (Link, 1995). This paralysis is attenuated by
insulin/IGF-1-pathway mutations (Cohen et al., 2006; Florez-
McClure et al., 2007). We wondered whether DAF-16 could
also act at a distance to counteract Ab toxicity. In multiple inde-
pendent lines, we found that Ab-containing daf-16(); daf-2()
adults expressing intestinal daf-16(+) moved much better than
did Ab-containing wild-type animals or daf-16(); daf-2()
mutants (Figures 6B, 6C, and S6E and Table S3). (As a control,
we introduced the Ab transgene back into wild-type and found
that it still induced paralysis [Table S3].) The ability of DAF-16
to counteract Ab toxicity correlated with its expression levels in
the intestine (Figure S6D & S6E). Thus, intestinally-expressed
DAF-16 can counteract Ab-dependent muscle dysfunction.
Likewise, mdt-15 RNAi, similar to daf-16 RNAi, also abolished
the ability of intestinal DAF-16 to delay Ab-dependent paralysis
(Figure 6D and Table S3).
DISCUSSION
Understanding how the insulin/IGF-1 endocrine system coordi-
nates the rate of aging among different tissues is fundamentally
important, as this pathway appears to influence the rate of aging
throughout the animal kingdom, from worms to man. In this
study, we analyzed the expression of a diverse collection of
DAF-16-regulated genes in vivo to better understand how
components of this signaling network map across the tissues
of the animal. One could imagine two extreme cases: in one,
DAF-16 would act at the end of an insulin/IGF-1 signal-transduc-
tion pathway, regulating downstream genes that affect only the
health and longevity of the cells in which they are expressed.
At the other extreme, since DAF-16 activity within a single tissuely
of wild-type and is upregulated mainly in the intestine (i), hypodermis (h,) and
(left): intestinal DAF-16 upregulates Pdod-11::rfp in the intestine as well as in
stinal GFP::DAF-16 (green) and Pdod-11::rfp (red). Note that one intestinal cell
panel (middle): muscle DAF-16 upregulates Pdod-11::rfp in muscles as well as
0 mm. In (B), left three panels: Intestinal cells expressing gfp::daf-16 and the
) cells are shown. Young adults, 400X magnification. Scale bar: 32 mm. Right
rference contrast (DIC, top) or fluorescence microscopy (RFP, bottom). Pdod-
ted in the intestine of daf-2()mutants. 1000X magnification. Scale bar: 13 mm.
in wild-type and is upregulated in the same tissues (‘‘i,’’ intestine; ‘‘h,’’ hypo-
column: intestinal DAF-16 upregulates Phsp-12.6::rfp in the intestine as well as
-12.6::rfp (red) (inset: RFP only). Muscle DAF-16 upregulates Phsp-12.6::rfp in
2.6 expression (bottom). Rectangle: coinjection marker Podr-1::rfp expression
-16 activity in muscles upregulates Phsp-12.6::rfp in muscle cells (m, oblong)
ts, 400X magnification. Scale bar: 32 mm.
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Figure 5. MDT-15 Is Required for dod-11 Expression and for Longevity
(A and B) RNAi of either daf-16 ormdt-15 attenuated Pdod-11::rfp expression in the intestine (i) and hypodermis (h) of (A) daf-2()mutants and (B) daf-16(); daf-
2()mutants expressing daf-16 in the intestine. Intestine-daf-16(+): muIs199. In (B), shown are Pdod-11::rfp expression (red, top panels) overlaid with intestinal
GFP::DAF-16 (green, bottom panels). Relative levels of Pdod-11::rfp expression in RNAi-treated animals are shown on the right (Kolmogorov-Smirnov test; n.s.,
not significant). Note that mdt-15 RNAi significantly reduced both the number and brightness of Pdod-11::rfp foci (this animal in [B] represents the ‘‘low-
expression’’ category), despite the high level of GFP::DAF-16. Rectangle: coinjection marker Podr-1::rfp expression in head neurons. Young adults, 250X
magnification. Scale bar: 50 mm.
(C) Knockdown of daf-16 or mdt-15 shortened the life span of daf-2() mutants to a greater extent than it affected wild-type (see Table S4). Log-rank test,
***p < 0.001.
(D)mdt-15 RNAi shortened the life span of daf-16(); daf-2()mutants, but had a greater life-shortening effect on daf-16(); daf-2() animals expressing daf-16
in the intestine (see Table S4). Log-rank test, **p < 0.01; ***p < 0.001.
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the whole animal, DAF-16 could regulate only downstream
signaling genes whose products then activate daf-16-indepen-
dent life-extension pathways in other cells. We find that both
mechanisms operate.
Limitations of Our Gene Set
Microarray analysis (Halaschek-Wiener et al., 2005; Lee et al.,
2009; McElwee et al., 2003; Murphy et al., 2003) and direct
DNA binding assays (Oh et al., 2006; Schuster et al., 2010) can
identify C. elegans genes that are likely to be regulated directly
versus indirectly by a transcription factor. Our in vivo imaging
analysis of DAF-16-regulated genes complements these
approaches and allows us to investigate the tissue specificity
and cell autonomy of gene expression. The genes we analyzed
have diverse functions, affecting protein homeostasis, innate
immunity, and metabolism, and many have been shown to
contribute to the long life spans of daf-2() mutants.
However, our analysis was biased against certain types of
genes. First, neural genes: Neurons are relatively resistant to
RNAi. RNAi was used in part of the microarray analysis from
which we selected genes to study, and in our initial assessment
of the daf-2 dependence of transgene expression. However,
previously, we showed that nonneuronal daf-2 RNAi doubles
life span, and that nonneuronal daf-16 RNAi completely
suppresses the life-span extension of daf-2() mutants (Libina
et al., 2003). Moreover, expressing daf-16 exclusively in neurons
in a daf-16(); daf-2() background produces only a small
increase in life span (Libina et al., 2003). Therefore, under-
standing the nonneuronal activities of DAF-16 is relevant for
understanding life-span regulation.
Second, because our reporters were driven by upstream DNA
sequences, we did not query potential regulatory sequences
within introns or coding sequences of DAF-16-regulated genes.
This is a concern, as the one translational fusion we did examine,
from mtl-1, was highly daf-2 responsive, whereas a transcrip-
tional fusion to the same promoter sequence did not respond
as well. In addition, we note that DAF-16 could potentially influ-
ence gene expression at the level of translation (McColl et al.,
2010), and this would not be assessed in our study.
Finally, important daf-2/daf-16-regulated genes with small
induction ratios would probably have escaped detection in our
assay—and we could have missed, simply by chance, key life-
span genes with properties that differ from the genes we
examined. Nevertheless, our analysis of this small gene set
suggests some interesting new features of this regulatory
network.
Three Modes of DAF-16 Gene Regulation
Together, our findings provide molecular support for the idea
that DAF-16 influences gene expression among the tissues of
C. elegans in three ways (Figure 6E). First, DAF-16 can act within
a tissue to regulate genes predicted to influence the health and
longevity of that tissue. Second, DAF-16 activates downstream
signal transduction cascades that act independently of daf-16
to regulate gene expression at a distance and to slow the
aging of other tissues (Libina et al., 2003) (this study) (FOXO-
to-FOXO() signaling). Third, as shown previously, DAF-16
regulates the expression of insulin-like genes (Murphy et al.,C2003), allowing DAF-16 activity in one tissue to affect DAF-16
activity elsewhere in the animal (FOXO-to-FOXO signaling)
(Murphy et al., 2007).
Cell-Autonomous Gene Regulation by DAF-16
Six of the nine daf-2/daf-16-responsive genes we examined
were regulated in a strictly cell-autonomous fashion by DAF-
16, as was the previously analyzed DAF-16-regulated gene
sod-3. This finding argues against themodel that DAF-16 directly
regulates only downstream signaling genes, whose effects on
other cells are completely responsible for life extension. Instead,
the behavior of this gene sample, which includes genes with
diverse functions, suggests that DAF-16 may activate numerous
types of cell-protective genes cell autonomously. All but one
promoter we analyzed contained canonical DAF-16-binding
elements. The presence of DBEs suggests direct DAF-16 regu-
lation, though our findings show that DBE-containing promoters,
such as the dod-11 and hsp-12.6 promoters, can also be
switched on by DAF-16 indirectly, through DAF-16’s activity in
other tissues. Conversely, DAF-16 could also act via a promoter
fragment that lacked canonical DBEs, apparently by binding
to suboptimal DBE sites, to the DAE/GATA site, and to other,
unidentified sequences. FOXO proteins possess chromatin-
remodeling ability (Hatta and Cirillo, 2007), so DAF-16may utilize
multiple binding sites to create a permissive environment for
gene expression.
All but one of the twenty daf-2-dependent transgenes we
examined (plus the control sod-3 transgene) were expressed
in the intestine, and eleven were expressed mainly or exclusively
in the digestive tract. This intestinal enrichment was highly sig-
nificant statistically (p = 1.1E-11; Table S1). Why might DAF-16
regulate so many intestinal genes? First, the intestine seems
to be particularly vulnerable to aging, undergoing extensive
tearing and deterioration (McGee et al., 2011). It is also a major
entry port for toxins and bacterial pathogens, and becomes
packed with bacteria with age (Garigan et al., 2002; McGee
et al., 2011). Bacterial packing and intestinal deterioration are
both reduced greatly by daf-2 mutations (Garigan et al., 2002;
McGee et al., 2011). Thus, DAF-16 may extend life and promote
stress resistance in part by ‘‘bullet-proofing’’ the intestine. For
instance, the intestinal metallothionein mtl-1 may protect the
animal from heavy metals it ingests. Finally, our 23 DAF-16-
regulated, intestine-expressed genes include at least 15 meta-
bolic genes (Table S1), raising the possibility that DAF-16 could
act in the intestine to help nourish the animals to improve
systemic health.
Insulin/IGF-1 signaling mutants are resistant to pathogenic
bacteria (Evans et al., 2008; Garsin et al., 2003), possibly due
to increased intestinal expression of the innate-immunity lyso-
zyme gene lys-7. The intestine-specific GATA-factor ELT-2
may act with DAF-16 to protect the intestine from infection,
as it is required for survival of wild-type animals exposed to
pathogens, and for intestinal expression of lys-7 (Figure 3A and
Table 1) and other lysozymes (Shapira et al., 2006).
Finally, we note that, because intestinal DNA makes up only
a small fraction of the animal’s DNA, the intestinal enrichment
of DAF-16-regulated genes could help explain why so few
DAF-16-regulated genes from microarrays have been identified
in chromatin profiling experiments (see Figure S4D, legend).ell Metabolism 17, 85–100, January 8, 2013 ª2013 Elsevier Inc. 95
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DAF-16 Activity Within and Across the TissuesGATA Factors Direct Expression of DAF-16-Regulated
Genes to Specific Tissues
DAF-16 is expressedwidely, andwe found that DAF-16 activates
genes tissue specifically, at least in part, by functioning in combi-
nation with tissue-specific GATA factors. The intestinal GATA-
factor ELT-2 and the hypodermal factor ELT-3 were required
for intestinal and hypodermal expression, respectively, of many
DAF-16-regulated genes. Our findings, both in vivo and in vitro,
suggest that GATA factors regulate these genes by binding to
their DAE/GATA site (as predicted previously by McGhee et al.,
2009, from DNA sequence). We note that some DAE-containing
DAF-16-regulated genes, such as lys-7 andmtl-1, are expressed
exclusively in the intestine (Tables 1 and S1). Presumably, these
genes contain additional sequences that prevent ELT-3 from
activating them in the hypodermis. In addition, some DAF-16-
regulated genes, like tps-1, were upregulated normally in both
the intestine and the hypodermis in spite of GATA factor RNAi.
Thus, DAF-16 does not absolutely require GATA factors to regu-
late gene expression in these tissues.
GATA Factors and Life Span
Since the intestinal GATA factor ELT-2 is needed for much
intestinal DAF-16-regulated gene expression, it seemed likely
that elt-2 knockdown would shorten the life span of daf-2()
mutants. We found that this was the case. Our data are consis-
tent with a very recent, independent report showing that elt-2
inactivation could disrupt cytoprotective gene expression and
shorten the life span of daf-2() mutants (Shore et al., 2012).
We found that elt-2 knockdown also shortened the life span
of calorically restricted eat-2() mutants substantially. This
life-span pathway is daf-16 independent but requires the
FOXA transcription factor, pha-4 (Panowski et al., 2007). Inter-
estingly, pha-4 expression is activated by ELT-2, and the two
proteins have been shown to coregulate specific genes (Ano-
kye-Danso et al., 2008).
Our findings also point to an important role for a new tissue,
the hypodermis, in life-span regulation by DAF-16, as hypo-
dermal-only daf-16 expression could extend the life span of
daf-16(); daf-2() mutants up to 30%. Because ELT-3 was
required for hypodermal expression of four DAF-16-regulated
genes we examined, one might expect that knocking down
ELT-3 expression would shorten the life span of daf-2()
mutants. However, as observed by theMcGhee group (Tonsaker
et al., 2012), this was not the case. (Our findings differ from those
from the Kim lab [Budovskaya et al., 2008] in some respects;
please see Figure S5 for discussion.) This finding implies thatFigure 6. Effects of Intestinal DAF-16 and MDT-15 on Muscle Aging an
(A) mdt-15 RNAi reduced the ability of intestinal DAF-16 to protect daf-16() m
treated animals on day 12 of adulthood. Each point represents one animal (three
more severe sarcomere degeneration. Mean degeneration index is indicated by
(B and C) Intestinal DAF-16 attenuated the toxicity of muscle-expressed Ab prote
Ab(1-42) is expressed in body-wall muscles (see Table S3). Log-rank test, ***p
paralysis of the animals shown in Figure 6B (see Table S3). Log-rank test, ***p <
(D) daf-16 ormdt-15 RNAi abolished the ability of intestinal DAF-16 to ameliorate
RNAi-treated animals were scored for paralysis at room temperature (see Table
(E) Model for daf-16-dependent gene regulation. First, DAF-16 can act directly on
tissue (e.g., intestine, muscle) can stimulate downstream signaling pathways t
aggregation toxicity (FOXO-to-FOXO() signaling). Analysis of MDT-15 suggests
action in one tissue can affect DAF-16 activity elsewhere, for example, by feedb
CDAF-16 regulates important hypodermal longevity genes inde-
pendently of ELT-3.
DAF-16 Action at a Distance: FOXO-to-FOXO(–)
Signaling
In this study, we extended the case for FOXO-to-FOXO()
signaling from the organismal level to the level of individual
tissues (aging muscles) and genes (specifically, two metabolic
genes dod-11 and dod-8, and one chaperone gene, hsp-12.6).
These findings put the concept of FOXO-to-FOXO() signaling
on solid molecular footing. DAF-16 action in the intestine, which
can extend life span substantially (by 50%–70%), affected dod-
11, hsp-12.6, and dod-8 expression in multiple tissues. In addi-
tion, DAF-16 could act in other tissues to affect gene expression
in the intestine and elsewhere. This latter finding can help to
explain how, given the fragility of the intestine, daf-2()mutants
can live 50% longer than wild-type if daf-16 is expressed only in
nonintestinal tissues (Libina et al., 2003). In that case, perhaps
DAF-16 can act at a distance to protect the intestine.
How canDAF-16 promote signaling across tissues?Others re-
ported that the gene scl-1 was a candidate downstream
signaling gene, but we were unable to confirm this in our studies
(see Supplemental Discussion). However, we identified a new
candidate, theDAF-16-regulated genemdt-15.MDT-15 is a tran-
scriptional mediator subunit that regulates genes involved in lipid
metabolism, so it could potentially induce lipid signals that act
across the tissues to affect life span. Loss of mdt-15 reduces
dod-11 expression in many tissues, including several that do
not appear to express mdt-15. Thus, MDT-15 appears to act
on the sending end of an intercellular signaling pathway that is
activated by DAF-16.
mdt-15(RNAi) animals are unhealthy. However, two findings
suggest that mdt-15 plays an important role in aging. First, loss
of mdt-15 accelerated age-dependent sarcomere deterioration
in daf-2() animals expressing intestine-only daf-16(+), but not
in daf-2() animals that were also daf-16() (Figure 6). Second,
mdt-15 inhibition had a greater life-shortening effect on daf-2()
mutants than it had on wild-type (Figure 5C). Rogers et al. (2011)
recently reported similar, independent findings and also showed
thatmdt-15 was required for life-span extension by inhibiting the
translation factor ifg-1/eIF4G. It will be interesting to learn more
about this potential downstream signaling pathway in the future.
FOXO-to-FOXO Signaling
DAF-16 can act at a distance to upregulate DAF-16 activity
elsewhere in the animal (Murphy et al., 2007). There are manyd Age-Related Disease
uscles during aging. Top: average sarcomere degeneration indexes of RNAi-
to four images were taken for each animal). Higher number (y axis) represents
the gray bar (Mann-Whitney-Wilcoxon test; n.s., not significant).
in. In (B), Kaplan-Meier survival analysis of transgenic animals in which human
< 0.001. n.s., not significant. In (C), age-dependent Ab aggregation-induced
0.001. n.s., not significant.
toxic Ab aggregation-induced paralysis. RNAi was initiated at the L4 stage, and
S3). Log-rank test, ***p < 0.001. n.s., not significant.
its target genes in a cell-autonomous fashion. Second, DAF-16 activity in one
hat act on daf-16() cells to influence gene expression, aging, and protein-
that downstream lipid signals may play a role in this signaling. Third, DAF-16
ack regulation of insulin genes (FOXO-to-FOXO signaling).
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certain tissues extends life span. However, in the great majority
of these cases, whether FOXO is required in other, wild-type
tissues is not known. These examples include (1) the extension
of life span caused by loss of daf-2 activity in the ectoderm
(skin, neurons) of C. elegans (Apfeld and Kenyon, 1998), as
well as (2) the suppression of longevity caused by neuron-only
daf-2 expression (or intestine or neuron-only age-1/PI3K expres-
sion) in daf-2 (or age-1) mutant worms (Iser et al., 2007; Wolkow
et al., 2000). Likewise, it is not known whether the ability of
neuronal age-1(+) to influence intestinal hsp gene expression in
C. elegans (Iser et al., 2011) requires intestinal FOXO activity.
In mice, brain-specific loss of the IGF-1 receptor (Kappeler
et al., 2008) or downstream IRS genes (Taguchi et al., 2007)
can increase life span. Activating FOXO or inhibiting insulin
signaling in adipose tissue can extend life span in flies (Gianna-
kou et al., 2004; Hwangbo et al., 2004) and mice (Blu¨her et al.,
2003). At least in flies, this condition appears to trigger FOXO-
to-FOXO signaling (Hwangbo et al., 2004), but whether it might
trigger FOXO-to-FOXO() signaling as well is not known. It
would be interesting to carry out these experiments in a foxo()
background to determine whether FOXO is required in respond-
ing tissues. Finally, given the importance of the C. elegans
intestine, as well as the hypodermis, in life-span regulation, it
would be interesting to ask whether insulin/IGF-1-pathway
members could send life-extending signals from the intestines
or the skin of higher organisms.DAF-16 Can Suppress Symptoms of Age-Related
Disease from a Distance
Long-lived insulin/IGF-1 mutants are resistant to many age-
related diseases, so we asked whether DAF-16 might act at
a distance in a disease setting. We found that, in a process
that requiresmdt-15, endodermal DAF-16 can partially suppress
the paralysis caused by expressing Ab in the muscles. DAF-16
and MDT-15 action could potentially reduce the expression
of Ab in muscles, or they could decrease the accumulation of
toxic Ab oligomer species. This finding is important, as it raises
the possibility that systemic, FOXO-dependent signals, perhaps
beneficial lipid signals, might be able to slow the progression
of Alzheimer’s disease, and possibly other age-related diseases,
in humans.EXPERIMENTAL PROCEDURES
Microscopy
Transgenic animals were analyzed at the young-adult stage. For quantitative
analysis, GFP fluorescence in the anterior quarter of the intestine was
measured using the OpenLab software.
Gel-Shift Assays
Proteins were expressed and purified from bacteria. Radioactively labeled
DNA oligos were mixed with proteins, resolved on a polyacrylamide gel, and
subjected to autoradiography.
Life-Span Analysis
Lifespan assays were performed as described (Apfeld and Kenyon, 1998).
RNAi was initiated at the young-adult stage. The prefertile period of adulthood
was used as t = 0 for life-span analysis. STATA software (version 10.1) was
used for statistical analysis.98 Cell Metabolism 17, 85–100, January 8, 2013 ª2013 Elsevier Inc.Paralysis
Worms expressing human Ab(1-42) in body-wall muscles were raised at 20C
and analyzed as adults. Worms that failed to move when touched with a plat-
inum wire were scored as ‘‘paralyzed’’ (Link, 1995). To avoid mis-scoring,
paralysis assays were terminated by day 8 of adulthood when wild-type
animals begin to move more slowly. RNAi-treatment was initiated at the L4
stage, and young adults were scored at room temperature (22.5C), which
accelerated paralysis and helped to distinguish Ab paralysis from aging effects
on motility.
SUPPLEMENTAL INFORMATION
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